CUE β€” CUE BIOPHARMA INC

Ownership history in XTX Topco Ltd  Β·  10 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in CUE BIOPHARMA INC (CUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.08% (2022 Q1)
πŸ“Š Avg. % of fund
0.02%
πŸ“… First filed
2022 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
10

Position Intelligence

XTX Topco Ltd Γ— CUE AI Analytics

πŸ“‰ XTX Topco Ltd underperformed the S&P 500 by –69.5% annually on this CUE position. Timing score: 44% (4/9 decisions correct). Average cost basis: $2.81. Maximum drawdown during holding period: –86.1%.

πŸ“ˆ Position Alpha vs SPY
-69.5%
annualised excess return

❌ Significantly underperformed the S&P 500 by 69.5% ann.
9 quarters analyzed

⏱️ Timing Score
44%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
4 of 9 add/trim decisions correct

πŸ’° Entry Quality
$2.81
-74.4% vs current ($0.72)

Best entry: $0.76 (2024 Q3)  Β·  Worst: $4.88 (2022 Q1)

πŸ›‘οΈ Drawdown Resilience
–86.1%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
50%
buy-side decisions

5 adds Β· 5 trims. Bought during 2 of 5 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    CUE price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 14,741 -7,752 -34.5% 0.00% $11K $0.72
2025 Q2 REDUCED 22,493 -4,451 -16.5% 0.00% $15K $0.68
2025 Q1 REDUCED 26,944 -20,029 -42.6% 0.00% $25K $0.91
2024 Q4 ADDED 46,973 +19,308 +69.8% 0.00% $51K $1.09
2024 Q3 ADDED 27,665 +12,361 +80.8% 0.00% $21K $0.76
2023 Q4 REDUCED 15,304 -37,966 -71.3% 0.01% $40K $2.64
2023 Q3 ADDED 53,270 +25,821 +94.1% 0.02% $123K $2.30
2022 Q3 REDUCED 27,449 -11,394 -29.3% 0.02% $61K $2.23
2022 Q2 ADDED 38,843 +3,544 +10.0% 0.04% $97K $2.49
2022 Q1 INITIATED 35,299 β€” β€” 0.08% $172K $4.88

🏒 Other funds also holding CUE

As of 2025 Q4 β€” sorted by position size

Lion Point Capital, LP 3Y 7Y 3.48% Bleichroeder LP 3Y 0.37% GC Wealth Management RIA, LLC 0.05% ADVISORY RESEARCH INC 3Y 7Y 0.01% ANGELES WEALTH MANAGEMENT, LLC 3Y 0.01% Robertson Stephens Wealth Management, LLC 3Y 7Y 0.0% BOOTHBAY FUND MANAGEMENT, LLC 3Y 7Y 0.0% PREVAIL INNOVATIVE WEALTH ADVISORS, LLC 0.0% Chicago Partners Investment Group LLC 3Y 7Y 0.0% New Millennium Group LLC 3Y 0.0%
← Back to XTX Topco Ltd Holdings